Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

The intelligence a $25K terminal charges for — the day it breaks, in your market, at a fraction of the price.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskPositive

Tectonic Therapeutic, Inc.

Filed: Jun 8, 2026CIK: 0001681087
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Tectonic Therapeutic elected Timothy A. Springer and Stefan Vitorovic as Class II directors at its June 8, 2026 Annual Meeting of Stockholders, strengthening board composition with strong stockholder support.

Key Takeaways

Timothy A. Springer and Stefan Vitorovic were elected as Class II directors to serve until the 2029 Annual Meeting

Springer received 11,461,485 votes and Vitorovic received 13,937,996 votes, demonstrating significant stockholder support

1 more takeaway

Filing Overview

Form Type8-K
Filing DateJun 8, 2026
Item5.02
CategoryExecutive Change
CIK0001681087
Accession #0001681087
Risk LevelLOW
SentimentPositive
Signalinformational
Topics
board changeleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings